ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,092,899 | +33.9% | 1,517,467 | +29.9% | 1.04% | +54.3% |
Q2 2023 | $23,215,373 | +56.2% | 1,168,363 | +34.6% | 0.67% | +53.1% |
Q1 2023 | $14,864,249 | -29.6% | 867,732 | -19.5% | 0.44% | -26.0% |
Q4 2022 | $21,100,452 | +164.4% | 1,078,204 | +115.6% | 0.59% | +155.6% |
Q3 2022 | $7,980,000 | -50.3% | 500,000 | -57.2% | 0.23% | -53.9% |
Q2 2022 | $16,056,000 | -39.7% | 1,166,883 | -30.5% | 0.50% | -5.6% |
Q1 2022 | $26,615,000 | -68.9% | 1,678,090 | -57.2% | 0.53% | -19.2% |
Q4 2021 | $85,536,000 | +23.9% | 3,918,250 | +69.6% | 0.66% | -34.2% |
Q3 2021 | $69,054,000 | -71.7% | 2,310,261 | -58.0% | 1.00% | -36.6% |
Q2 2021 | $243,736,000 | +91.6% | 5,503,206 | +91.9% | 1.58% | -1.6% |
Q1 2021 | $127,243,000 | -31.7% | 2,867,771 | -15.6% | 1.61% | -19.5% |
Q4 2020 | $186,284,000 | +272.3% | 3,396,867 | +55.2% | 2.00% | +173.5% |
Q3 2020 | $50,041,000 | +9.2% | 2,189,010 | 0.0% | 0.73% | -1.5% |
Q2 2020 | $45,816,000 | +50.0% | 2,189,010 | 0.0% | 0.74% | -6.7% |
Q1 2020 | $30,537,000 | -40.1% | 2,189,010 | -2.2% | 0.80% | -21.4% |
Q4 2019 | $50,965,000 | +121.2% | 2,239,241 | +13.2% | 1.01% | +63.0% |
Q3 2019 | $23,037,000 | -22.3% | 1,977,412 | 0.0% | 0.62% | -8.8% |
Q2 2019 | $29,661,000 | +269.1% | 1,977,412 | +331.6% | 0.68% | +200.0% |
Q1 2019 | $8,036,000 | +129.9% | 458,173 | +90.8% | 0.23% | +70.7% |
Q4 2018 | $3,495,000 | – | 240,173 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |